首页> 外文期刊>clinical nuclear medicine >Use of Fusion Images of I-131 Metaiodobenzylguanidine, SPECT, and Magnetic Resonance Studies to Identify a Malignant Pheochromocytoma
【24h】

Use of Fusion Images of I-131 Metaiodobenzylguanidine, SPECT, and Magnetic Resonance Studies to Identify a Malignant Pheochromocytoma

机译:Use of Fusion Images of I-131 Metaiodobenzylguanidine, SPECT, and Magnetic Resonance Studies to Identify a Malignant Pheochromocytoma

获取原文
           

摘要

Pheochromocytoma is a chromaffin tumor in which 10percnt; are extra-adrenal and 10percnt; are malignant. I-131 metaiodobenzylguanidine (MIBG) scintigraphy has an important role in the identification of these tumors and investigation of metastatic lesions. The authors describe a 36-year-old woman who underwent resection of a malignant left adrenal pheochromocytoma who was thought to have metastases in the liver and para-aortic lymph nodes. Fusion images of I-131 MIBG SPECT and magnetic resonance studies were obtained to properly identify the metastatic lesions. These fusion images helped greatly in subsequent surgery.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号